Literature DB >> 17702991

Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia.

Dwight Dickinson1, James M Gold.   

Abstract

The magnitude of the overlap among dimensions of neuropsychological test performance in schizophrenia has been the subject of perennial controversy. This issue has taken on renewed importance with the recent focus on cognition as a treatment target in schizophrenia. A substantial body of factor analytic literature indicates that dimensions are separable in schizophrenia. However, this literature is generally uninformative as to whether the separable dimensions are independent, weakly correlated, or strongly correlated. Factor analyses have often used methods (ie, principal components analysis with orthogonal rotation) that preclude this determination, and correlations among factor-based domain composites and underlying measures have been reported infrequently in these studies. Current meta-analyses of reported "between-dimension" correlations for individual neuropsychological measures and for cognitive domain composite variables indicate that cognition variables in schizophrenia are correlated, on average, at a "medium" level of r = 0.37 for individual measures from different cognitive dimensions and r = 0.45 for domain composites. Because these are mean bivariate correlations, the multiple correlation of an individual measure with all the other measures in a cognitive battery is likely to be higher. Measure reliabilities of 0.80 or less also imply greater commonality among traditional neuropsychological measures. In short, there are underappreciated constraints on the amount of reliable cognitive performance variance in traditional neuropsychological test batteries that is free to vary independently. The ability of such batteries to reveal cognitive domain-specific treatment effects in schizophrenia may be much more limited than is generally assumed.

Entities:  

Mesh:

Year:  2007        PMID: 17702991      PMCID: PMC2632436          DOI: 10.1093/schbul/sbm092

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  51 in total

1.  Factor structure of the Wechsler Adult Intelligence Scale-III in schizophrenia.

Authors:  Dwight Dickinson; Virginia N Iannone; James M Gold
Journal:  Assessment       Date:  2002-06

2.  Computerized neurocognitive scanning: II. The profile of schizophrenia.

Authors:  R C Gur; J D Ragland; P J Moberg; W B Bilker; C Kohler; S J Siegel; R E Gur
Journal:  Neuropsychopharmacology       Date:  2001-11       Impact factor: 7.853

3.  The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements.

Authors:  Philip D Harvey; Michael F Green; Christopher Bowie; Antony Loebel
Journal:  Psychopharmacology (Berl)       Date:  2006-06-17       Impact factor: 4.530

4.  Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia.

Authors:  Christopher M Wilk; James M Gold; John J Bartko; Faith Dickerson; Wayne S Fenton; Michael Knable; Christopher Randolph; Robert W Buchanan
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

5.  Relative risk for cognitive impairments in siblings of patients with schizophrenia.

Authors:  M F Egan; T E Goldberg; T Gscheidle; M Weirich; R Rawlings; T M Hyde; L Bigelow; D R Weinberger
Journal:  Biol Psychiatry       Date:  2001-07-15       Impact factor: 13.382

6.  Do specific neurocognitive deficits predict specific domains of community function in schizophrenia?

Authors:  D I Velligan; C C Bow-Thomas; R K Mahurin; A L Miller; L C Halgunseth
Journal:  J Nerv Ment Dis       Date:  2000-08       Impact factor: 2.254

7.  Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.

Authors:  S E Purdon; B D Jones; E Stip; A Labelle; D Addington; S R David; A Breier; G D Tollefson
Journal:  Arch Gen Psychiatry       Date:  2000-03

8.  Stability and course of neuropsychological deficits in schizophrenia.

Authors:  R K Heaton; J A Gladsjo; B W Palmer; J Kuck; T D Marcotte; D V Jeste
Journal:  Arch Gen Psychiatry       Date:  2001-01

9.  Neurocognitive dimensions characterising patients with first-episode psychosis.

Authors:  S Friis; K Sundet; B R Rund; P Vaglum; T H McGlashan
Journal:  Br J Psychiatry Suppl       Date:  2002-09

10.  The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone.

Authors:  Michael F Green; Stephen R Marder; Shirley M Glynn; Susan R McGurk; William C Wirshing; Donna A Wirshing; Robert P Liberman; Jim Mintz
Journal:  Biol Psychiatry       Date:  2002-06-15       Impact factor: 13.382

View more
  16 in total

1.  Cognitive factor structure and invariance in people with schizophrenia, their unaffected siblings, and controls.

Authors:  Dwight Dickinson; Terry E Goldberg; James M Gold; Brita Elvevåg; Daniel R Weinberger
Journal:  Schizophr Bull       Date:  2010-03-29       Impact factor: 9.306

2.  Effects of risperidone and olanzapine dose reduction on cognitive function in stable patients with schizophrenia: an open-label, randomized, controlled, pilot study.

Authors:  Hiroyoshi Takeuchi; Takefumi Suzuki; Gary Remington; Robert R Bies; Takayuki Abe; Ariel Graff-Guerrero; Koichiro Watanabe; Masaru Mimura; Hiroyuki Uchida
Journal:  Schizophr Bull       Date:  2013-07-01       Impact factor: 9.306

3.  Neural correlates of global and specific cognitive deficits in schizophrenia.

Authors:  Robert J Jirsaraie; Julia M Sheffield; Deanna M Barch
Journal:  Schizophr Res       Date:  2018-06-25       Impact factor: 4.939

4.  Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment.

Authors:  Elsa Gilbert; Chantal Mérette; Valérie Jomphe; Claudia Emond; Nancie Rouleau; Roch-Hugo Bouchard; Marc-André Roy; Thomas Paccalet; Michel Maziade
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-10-31       Impact factor: 5.270

5.  Development and testing of a web-based battery to remotely assess cognitive health in individuals with schizophrenia.

Authors:  Bruno Biagianti; Melissa Fisher; Benjamin Brandrett; Danielle Schlosser; Rachel Loewy; Mor Nahum; Sophia Vinogradov
Journal:  Schizophr Res       Date:  2019-02-04       Impact factor: 4.939

6.  Clinical, functional, and intertask correlations of measures developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium.

Authors:  James M Gold; Deanna M Barch; Cameron S Carter; Steven Dakin; Steven J Luck; Angus W MacDonald; J Daniel Ragland; Charan Ranganath; Ilona Kovacs; Steven M Silverstein; Milton Strauss
Journal:  Schizophr Bull       Date:  2011-11-17       Impact factor: 9.306

Review 7.  What do we know about neuropsychological aspects of schizophrenia?

Authors:  Barton W Palmer; Sharron E Dawes; Robert K Heaton
Journal:  Neuropsychol Rev       Date:  2009-07-30       Impact factor: 7.444

8.  A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state.

Authors:  Matthew M Kurtz; Raphael T Gerraty
Journal:  Neuropsychology       Date:  2009-09       Impact factor: 3.295

9.  Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem.

Authors:  Dwight Dickinson; Philip D Harvey
Journal:  Schizophr Bull       Date:  2008-08-09       Impact factor: 9.306

10.  General and specific cognitive deficits in schizophrenia: Goliath defeats David?

Authors:  Dwight Dickinson; J Daniel Ragland; James M Gold; Ruben C Gur
Journal:  Biol Psychiatry       Date:  2008-05-09       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.